Share
Export Citation
APA
MLA
Chicago
Harvard
Vancouver
BIBTEX
RIS
Universitas Hasanuddin
Research output:Contribution to journal›Article›peer-review
Candesartan as a tentative treatment for COVID-19: A prospective non-randomized open-label study
Lukito A.A.
International Journal of Infectious Diseases
Q1Published: 2021Citations: 11
Abstract
Candesartan significantly reduces the length of hospital stay after adjustment for covariates. All primary outcomes improved significantly in the non-obese subgroup receiving candesartan.
Access to Document
10.1016/j.ijid.2021.05.019Other files and links
- Link to publication in Scopus
- Open Access Version Available
Fingerprint
MedicineSciences
CandesartanSciences
Hazard ratioSciences
Confidence intervalSciences
ConfoundingSciences
Internal medicineSciences
Randomized controlled trialSciences
RegimenSciences
Proportional hazards modelSciences
Prospective cohort studySciences
Subgroup analysisSciences
Angiotensin IISciences
Blood pressureSciences